Skip to main content
Top
Published in: The Journal of Headache and Pain 1/2015

Open Access 01-12-2015 | Invited speaker presentation

Obesity, diet and nutraceuticals

Authors: Cherubino Di Lorenzo, Gianluca Coppola

Published in: The Journal of Headache and Pain | Special Issue 1/2015

Login to get access

Excerpt

Migraine is the most prevalent neurological disorder worldwide, affecting on average 12% of the general population. Recent data support migraine as part of the metabolic syndrome (MetSyn) spectrum. The evidence of an association between obesity, insulin resistance, and migraine, all having in common the ability to favor a general pro-inflammatory state, reinforces this view. Under a neuronal point of view, another possible link between migraine and MetSyn is, other than the inflammatory state, the cellular energetic deficit. Indeed, it is well known that a mitochondrial energetic dysfunction may play a role in migraine pathogenesis, that MetSyn could further impair mitochondrial metabolism increasing oxidative stress, and that nutraceuticals involved in mitochondrial oxidative phosphorylation (OXPHOS) metabolism (Riboflavin, CoQ10, and magnesium) can be used as migraine prophylactic treatments. Here we review the evidence of MetSyn and migraine association and possible therapeutic implications. …
Metadata
Title
Obesity, diet and nutraceuticals
Authors
Cherubino Di Lorenzo
Gianluca Coppola
Publication date
01-12-2015
Publisher
Springer Milan
Published in
The Journal of Headache and Pain / Issue Special Issue 1/2015
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-16-S1-A28

Other articles of this Special Issue 1/2015

The Journal of Headache and Pain 1/2015 Go to the issue

Invited speaker presentation

Trigeminal neuralgia